Alumis, Inc. (ALMS)
23.03
-1.14
(-4.72%)
USD |
NASDAQ |
Aug 24, 16:00
23.01
-0.02
(-0.09%)
Pre-Market: 20:00
Alumis Market Cap : 2.959B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.959B |
| August 21, 2026 | 3.106B |
| August 20, 2026 | 2.938B |
| August 19, 2026 | 3.083B |
| August 18, 2026 | 3.197B |
| August 17, 2026 | 3.277B |
| August 14, 2026 | 3.252B |
| August 13, 2026 | 3.137B |
| August 12, 2026 | 3.283B |
| August 11, 2026 | 3.260B |
| August 10, 2026 | 3.503B |
| August 07, 2026 | 3.512B |
| August 06, 2026 | 3.537B |
| August 05, 2026 | 3.450B |
| August 04, 2026 | 3.450B |
| August 03, 2026 | 3.323B |
| July 31, 2026 | 3.594B |
| July 30, 2026 | 3.683B |
| July 29, 2026 | 3.356B |
| July 28, 2026 | 3.439B |
| July 27, 2026 | 3.445B |
| July 24, 2026 | 3.562B |
| July 23, 2026 | 3.601B |
| July 22, 2026 | 3.665B |
| July 21, 2026 | 3.823B |
| Date | Value |
|---|---|
| July 20, 2026 | 3.560B |
| July 17, 2026 | 3.646B |
| July 16, 2026 | 3.464B |
| July 15, 2026 | 3.665B |
| July 14, 2026 | 3.471B |
| July 13, 2026 | 3.575B |
| July 10, 2026 | 3.602B |
| July 09, 2026 | 3.855B |
| July 08, 2026 | 3.784B |
| July 07, 2026 | 3.724B |
| July 06, 2026 | 3.470B |
| July 02, 2026 | 3.372B |
| July 01, 2026 | 3.389B |
| June 30, 2026 | 3.580B |
| June 29, 2026 | 3.453B |
| June 26, 2026 | 3.359B |
| June 25, 2026 | 3.185B |
| June 24, 2026 | 3.162B |
| June 23, 2026 | 3.118B |
| June 22, 2026 | 3.130B |
| June 18, 2026 | 2.978B |
| June 17, 2026 | 2.933B |
| June 16, 2026 | 2.840B |
| June 15, 2026 | 2.926B |
| June 12, 2026 | 3.073B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 13.30B |
| Aclaris Therapeutics, Inc. | 882.29M |
| Crinetics Pharmaceuticals, Inc. | 8.970B |
| Tarsus Pharmaceuticals, Inc. | 3.151B |
| Structure Therapeutics, Inc. | 3.490B |
Market Cap Related Metrics
| PS Ratio | 359.21 |
| Price to Book Value | 6.545 |
| Price | 23.03 |
| Earnings Yield | -16.54% |